目的分析头孢哌酮钠舒巴坦钠西药注射的临床效果及不良反应情况。方法借助数字随机法,从阿勒泰地区哈萨克医院药剂科收治的炎症患者中选择60例展开研究,平均分作两组,即研究组30例,常规组30例;其中常规组炎症采用头孢他啶静脉注射,研究组则采取头孢哌酮钠舒巴坦钠静脉注射,研究对比两组炎症患者的效果及发生不良反应的情况。结果研究组临床治疗总有效率为93.33%,不良反应的发生率为20.0%;常规组临床治疗总有效率为76.67%,不良反应的发生率为6.67%,研究组治疗总有效率显著高于常规组,但不良反应的发生率显著低于常规组,两组数据对比具有统计学意义(P<0.05)。结论对炎症患者采取头孢哌酮钠舒巴坦钠静脉注射,治疗效果颇为显著,但不良反应率较高,需谨慎给药。 Objective To analyze the clinical effects and adverse reactions of cefoperazone sodium and sulbactam sodium injection. Methods According to the digital randomization method, 60 patients with inflammatory diseases were selected from the Kazak Hospital of Altay Prefecture. The average scores were divided into two groups, 30 in the study group and 30 in the conventional group. The patients in the conventional group were treated with intravenous injection of ceftazidime, The study group was taking cefoperazone sodium and sulbactam sodium intravenous injection, the study compared the two groups of patients with inflammatory response and the occurrence of adverse reactions. Results The total effective rate of clinical treatment in study group was 93.33% and the incidence of adverse reactions was 20.0%. The total effective rate of clinical treatment in conventional group was 76.67% and the incidence of adverse reactions was 6.67%. The total effective rate in study group was significantly higher than that in study group Conventional group, but the incidence of adverse reactions was significantly lower than the conventional group, the two groups of data was statistically significant (P <0.05). Conclusion Inflammatory patients taking cefoperazone sodium and sulbactam sodium intravenous injection, the treatment effect is quite significant, but the high rate of adverse reactions, need to be cautiously administered.